Enhance the patient experience with avoidance of the 1st pass metabolism
With unparalleled expertise in transdermal adhesives, ARx, LLC., carefully formulates and designs transdermal patch delivery systems for sustained release for up to 7 days and avoidance of the 1st pass metabolism. We custom develop and manufacture in support of both branded and generic pharmaceutical applications. Leveraging over 30 years of transdermal adhesive expertise, excipients are carefully selected to assure patient comfort during wear and to achieve the intended drug delivery profile. Material selection is further complemented by options for chemically compatible release liners to complete the product construction. Formulation scientists carefully design both single- and multi-layered patches for specialized drug delivery up to seven days.
Transdermal patches have been providing patients with enhanced compliance and convenience for over 30 years.
Benefits of ARx transdermal patch delivery systems for your drug, your patient, and your brand:
| Your Drug | Your Patient | Your Brand |
|---|---|---|
| Enhanced bioavailability through elimination of the first pass effect | Minimized frequency of dosing with long-term wear | Market success through enhanced patient compliance |
| Controlled systemic delivery over several hours to 1 week | Comfortable and discreet during dosing | Novel dosage form through produce line extension |
| Ultra-clean adhesive and excipient selection for toxicology testing | Eliminates the need to swallow medication | Customized size, shape, thickness, and color for brand recognition |
| Optimal stability and API compatibility with single or multi-layer systems | Immediate cessation to dosing upon patch removal | Individually pouched units offer additional space for printing logos and brand names |